Related party transactions deserve more than a line item in the board pack. They sit at the intersection of governance, valuation, disclosure, audit scrutiny and director independence. For independent directors, the question is not merely whether management says the transaction is permitted. The question is whether the board process shows that the transaction was identified, tested and approved with proper safeguards.
The ICSI reference material on SEBI LODR Regulations, 2015 and the Companies Act, 2013 is a useful official governance source because it places listed-entity obligations and company-law expectations side by side. In practice, related party transaction oversight should connect the audit committee, board, company secretary, finance team and external advisors. A scattered process is where avoidable exposure usually begins.
The first control is identification. Companies should maintain a current list of related parties, update it when shareholding, control, directorship or group arrangements change, and map proposed transactions against that list before commercial teams commit. A transaction discovered after execution is not oversight; it is archaeology with better stationery. Identification also requires contract teams to ask the question before pricing, supply or payment terms are finalised.
The second control is classification. The board pack should state whether the transaction is ordinary course, arm's length, material, recurring, exceptional, or part of a broader group arrangement. Independent directors should ask why that classification is supported. If management relies on a benchmarking note, valuation report, transfer pricing analysis or contract comparison, the relevant summary should be available. The board should not be asked to approve a label without seeing the basis for it.
The third control is approval discipline. The audit committee should see the transaction before approval where required, with clear papers on counterparty, commercial rationale, value, pricing basis, duration, payment terms, conflict handling and disclosure treatment. Interested directors should not participate where the legal framework requires recusal. The record should show the process actually followed, not only the final conclusion. A clean approval trail is the cheapest form of later defence.
Independent directors should also test whether the transaction creates a pattern. One isolated service agreement may be routine. Repeated advances, back-to-back purchases, asset transfers, guarantees or management-fee arrangements may indicate a governance issue. The board should ask whether similar transactions have been aggregated for materiality and whether shareholder approval is required. Patterns matter because risk often arrives politely, one small invoice at a time.
Disclosure should be treated as a separate control, not an afterthought. The company should confirm what must be reported to the board, stock exchanges, shareholders, auditors and financial statements. A transaction can be commercially defensible and still poorly disclosed. That is an expensive way to learn that governance and accounting sit in the same room.
The minutes should record the key questions: why the related party was chosen, how pricing was tested, whether alternatives were considered, who abstained, what documents were reviewed, and whether continuing monitoring is required. Minutes need not become a witness statement, but they should show the substance of oversight. If the transaction will continue over time, renewal, variation and payment performance should return to the committee.
A robust related party process protects the company and independent directors. It also protects legitimate group transactions from suspicion by creating a clear trail of evaluation, approval and disclosure. The aim is not to stop every group transaction; it is to make sure the board can explain why a proper one was approved.
For companies reviewing related party transaction controls, AGS Consulting can assess board packs, approval matrices and disclosure workflows. To review your governance process, contact AGS Consulting for advisory support.
FAQs
What should independent directors check in a related party transaction?
They should check identification, arm's length basis, commercial rationale, approval route, conflict handling, materiality and disclosure treatment.
Is audit committee approval always enough?
Not always. Materiality, listing status, shareholder approval requirements and specific transaction structure may require additional steps.
Should interested directors participate in the discussion?
Where the law or governance policy requires recusal, interested directors should not participate in approval and the minutes should record this clearly.
Why does benchmarking matter?
Benchmarking helps show whether pricing and terms are commercially defensible rather than influenced by the relationship between parties.